Literature DB >> 17512623

Hypoxia induced expression of endogenous markers in vitro is highly influenced by pH.

Brita Singers Sørensen1, Jan Alsner, Jens Overgaard, Michael R Horsman.   

Abstract

BACKGROUND: Genes such as carbonic anhydrase IX (Ca9), glucose transporter 1 (Glut1), lactate dehydrogenase A (LDH-A), osteopontin (OPN) and lysyl oxidase (LOX) have been suggested as hypoxic markers, but inconsistent results suggest that factors other than oxygen influence their expression. The current study is a detailed investigation using a range of pH values from 6.3 to 7.5 in two human cell lines to establish the pH dependency of hypoxia induced gene expression.
METHODS: Human tumour cell lines (uterine cervix squamous cell carcinoma (SiHa) and pharyngeal squamous cell carcinoma [FaDu(DD)]) were used. Hypoxia was induced by gassing cells in airtight chambers with various oxygen concentrations (21%, 1%, 0.1%, 0.01% and 0%) for up to 24h. The media were titrated to a range of pH values (7.5, 7.0, 6.7, 6.5 and 6.3). Gene expression was determined by real-time PCR.
RESULTS: In both SiHa and FaDu(DD) cells Ca9 and LOX reached the highest level of expression at 1% oxygen. In FaDu(DD) cells, a pH of 6.5 had a medium suppression effect on the hypoxia induced expression of Ca9. pH 6.3 resulted in severe suppression of expression for Ca9 and LOX in both SiHa and FaDu(DD). Glut1 and LDH-A had a similar expression pattern to each other, with a maximum expression at 0.01% oxygen, in both cell lines. For these genes pH 6.5 and 6.3 changed the expression pattern in SiHa cells. OPN was up regulated at low oxygen in SiHa cells, but was not induced by hypoxia in FaDu(DD) cells.
CONCLUSION: As tumour hypoxia occurs in a deprived microenvironment, other environmental factors, for example low pH, might interact with the effect of low oxygen concentration on gene expression. This study shows that pH in two cell lines has a profound influence on the oxygen dependent induction of certain endogenous hypoxic markers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17512623     DOI: 10.1016/j.radonc.2007.04.028

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  19 in total

Review 1.  Imaging hypoxia to improve radiotherapy outcome.

Authors:  Michael R Horsman; Lise Saksø Mortensen; Jørgen B Petersen; Morten Busk; Jens Overgaard
Journal:  Nat Rev Clin Oncol       Date:  2012-11-13       Impact factor: 66.675

2.  Lactate dehydrogenase production in hepatocytes is increased at an early stage of acute liver failure.

Authors:  Kazuhiro Kotoh; Masaki Kato; Motoyuki Kohjima; Masatake Tanaka; Masayuki Miyazaki; Kazuhiko Nakamura; Munechika Enjoji; Makoto Nakamuta; Ryoichi Takayanagi
Journal:  Exp Ther Med       Date:  2011-01-19       Impact factor: 2.447

3.  Functional interaction between responses to lactic acidosis and hypoxia regulates genomic transcriptional outputs.

Authors:  Xiaohu Tang; Joseph E Lucas; Julia Ling-Yu Chen; Gregory LaMonte; Jianli Wu; Michael Changsheng Wang; Constantinos Koumenis; Jen-Tsan Chi
Journal:  Cancer Res       Date:  2011-12-01       Impact factor: 12.701

4.  Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis.

Authors:  Elena Andreucci; Silvia Peppicelli; Fabrizio Carta; Giulia Brisotto; Eva Biscontin; Jessica Ruzzolini; Francesca Bianchini; Alessio Biagioni; Claudiu T Supuran; Lido Calorini
Journal:  J Mol Med (Berl)       Date:  2017-09-19       Impact factor: 4.599

5.  Small interfering RNA targeting HIF-1α reduces hypoxia-dependent transcription and radiosensitizes hypoxic HT 1080 human fibrosarcoma cells in vitro.

Authors:  Adrian Staab; Markus Fleischer; Juergen Loeffler; Harun M Said; Astrid Katzer; Christian Plathow; Herrmann Einsele; Michael Flentje; Dirk Vordermark
Journal:  Strahlenther Onkol       Date:  2011-03-25       Impact factor: 3.621

6.  EPR oxygen imaging and hyperpolarized 13C MRI of pyruvate metabolism as noninvasive biomarkers of tumor treatment response to a glycolysis inhibitor 3-bromopyruvate.

Authors:  Shingo Matsumoto; Keita Saito; Hironobu Yasui; H Douglas Morris; Jeeva P Munasinghe; Martin Lizak; Hellmut Merkle; Jan Henrik Ardenkjaer-Larsen; Rajani Choudhuri; Nallathamby Devasahayam; Sankaran Subramanian; Alan P Koretsky; James B Mitchell; Murali C Krishna
Journal:  Magn Reson Med       Date:  2012-06-12       Impact factor: 4.668

7.  Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4.

Authors:  Saskia E Rademakers; Jasper Lok; Albert J van der Kogel; Johan Bussink; Johannes H A M Kaanders
Journal:  BMC Cancer       Date:  2011-05-12       Impact factor: 4.430

8.  In vivo identification and specificity assessment of mRNA markers of hypoxia in human and mouse tumors.

Authors:  Morten Busk; Kasper Toustrup; Brita S Sørensen; Jan Alsner; Michael R Horsman; Steen Jakobsen; Jens Overgaard
Journal:  BMC Cancer       Date:  2011-02-09       Impact factor: 4.430

9.  The genomic analysis of lactic acidosis and acidosis response in human cancers.

Authors:  Julia Ling-Yu Chen; Joseph E Lucas; Thies Schroeder; Seiichi Mori; Jianli Wu; Joseph Nevins; Mark Dewhirst; Mike West; Jen-Tsan Chi
Journal:  PLoS Genet       Date:  2008-12-05       Impact factor: 5.917

10.  Effects of HIF-1 inhibition by chetomin on hypoxia-related transcription and radiosensitivity in HT 1080 human fibrosarcoma cells.

Authors:  Adrian Staab; Jürgen Loeffler; Harun M Said; Désirée Diehlmann; Astrid Katzer; Melanie Beyer; Markus Fleischer; Franz Schwab; Kurt Baier; Hermann Einsele; Michael Flentje; Dirk Vordermark
Journal:  BMC Cancer       Date:  2007-11-13       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.